4//SEC Filing
Holloway Michael Andrew 4
Accession 0001641172-25-024575
CIK 0001335105other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 2:56 PM ET
Size
5.9 KB
Accession
0001641172-25-024575
Insider Transaction Report
Form 4
Holloway Michael Andrew
Director
Transactions
- Award
Options to Purchase Common Stock
2025-08-15+25,000→ 25,000 totalExercise: $3.59From: 2025-08-15Exp: 2030-08-15→ Common (25,000 underlying)
Footnotes (1)
- [F1]Effective August 15, 2025, the reporting person was granted stock options to purchase 25,000 shares vesting 50% on the effective date, the remaining 50% vesting 12.5% on December 31, 2025 and on the last day of each subsequent calendar quarter until fully vested, subject to continuous service. The grant was in connection with the reporting person being appointed to the Company's Board of Directors. The exercise price is $3.59 per share.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0002076371
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 2:56 PM ET
- Size
- 5.9 KB